Addressing Metabolic Dysfunction as an Independent Cancer Risk Factor Accumulating evidence positions metabolic dysfunction characterised by insulin resistance, hepatic steatosis, dyslipidaemia, and visceral adiposity as a more powerful and proximate predictor of cancer risk than elevated body weight alone
Andrej Jane has served as a consultant and is on speakers bureaus for AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk, and Sanofi
Our team reviews your coverage and matches you with a provider who aligns with your plan
Glutathione also plays a key role in energy production and methylation, two critical processes at the core of normal cellular function
1.9%), and weight increased (3.7% vs